Potashman, M., Rudell, K., Suminski, N., Doma, R., Heinrich, M., Abetz-Webb, L., Beiner, M. W., Coric, V., Rosenthal, L. S., Kuo, S.-H., Zesiewicz, T., Fife, T. D., van de Warrenburg, B., Ristori, G., Synofzik, M., Subramony, S., Perlman, S., Schmahmann, J. D., & L’Italien, G. (2025). Content Validity of the Friedreich Ataxia Rating Scale in Patients with Spinocerebellar Ataxia. Neurology and Therapy, 14(2), 547–563. https://doi.org/10.1007/s40120-024-00704-8

Williams, M. J., Amezcua, L., Chinea, A., Cohan, S., Okai, A., Okuda, D. T., Vargas, W., Belviso, N., Božin, I., Jiang, X., Lewin, J. B., Lyons, J., Shen, C., England, S. M., & Grimes, N. (2023). Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM. Neurology and Therapy, 12(5), 1669–1682. https://doi.org/10.1007/s40120-023-00517-1

Amezcua, L., Mao-Draayer, Y., Vargas, W. S., Farber, R., Schaefer, S., Branco, F., England, S. M., Belviso, N., Lewin, J. B., Mendoza, J. P., & Shankar, S. L. (2023). Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies. Neurology and Therapy, 12(3), 883–897. https://doi.org/10.1007/s40120-023-00475-8

Tahami Monfared, A. A., Stern, Y., Doogan, S., Irizarry, M., & Zhang, Q. (2023). Understanding Barriers Along the Patient Journey in Alzheimer’s Disease Using Social Media Data. Neurology and Therapy, 12(3), 899–918. https://doi.org/10.1007/s40120-023-00472-x

Chiriboga, C. A., Bruno, C., Duong, T., Fischer, D., Mercuri, E., Kirschner, J., Kostera-Pruszczyk, A., Jaber, B., Gorni, K., Kletzl, H., Carruthers, I., Martin, C., Warren, F., Scalco, R. S., Wagner, K. R., Muntoni, F., Deconinck, N., Balikova, I., … Collado, J. (2023). Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study. Neurology and Therapy, 12(2), 543–557. https://doi.org/10.1007/s40120-023-00444-1